from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3811/-

LFCtreatmentdescriptionclass of inhibitor

-0.584

Amikacinug/mL Amikacintranslation

0.283

Cap5-10ug/mL Capreomycintranslation

-0.481

Rox10-50 ug/mL Roxithromycintranslation

-0.105

SM2-5 ug/mL Streptomycintranslation

-0.914

Tet5-10 ug/mL Tetracyclinetranslation

-1.084

Rif0.2-5ug/mL Rifampicintranscription

0.114

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.427

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.027

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.490

CPZ10-50 ug/mL Chlorpromazinerespiration

0.502

Clofazimine10-13 ug/mL Clofaziminerespiration

0.742

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.427

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.032

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.839

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.402

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.285

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.315

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.229

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.054

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.962

KCN5-20 ug/mL Potassium cyaniderespiration

0.403

NaN30.2-2 mM Sodium aziderespiration

0.528

Nigericin50 uM Nigericinrespiration

-0.333

TRC10-150 ug/mL Triclosanrespiration

0.161

TRZ10-25 ug/mL Thioridazinerespiration

-0.528

Valinomycin0.5-10 uM Valinomycinrespiration

1.637

ZnSO42 mM ZnSO4respiration

-0.832

menadione6-10 ug/mL Menadionerespiration

-0.873

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.476

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.236

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.027

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.706

NRP_1Non-replicating persistence stage 1dosRassociated

0.796

Amp0.2mg/mL AmpicillincellWall

0.945

Cephalexin20-100 ug/mL CephalexincellWall

0.298

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.163

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.349

EMB10-20 ug/mL EthambutolcellWall

0.182

Eta12-40 ug/mL EthionamidecellWall

0.044

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.246

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.454

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.620

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.281

BZA0.12 mg/mL BenzamidearomaticAmides

-0.606

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.529

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.726

H2O24 mM hydrogen peroxideDNAdamaging

0.176

Levo10 ug/mL LevofloxacinDNAdamaging

-0.916

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

4.079

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.042

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.692

UVUV-irradiationDNAdamaging

-1.350

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.557

Antimycin12.5-50 ug/mL Antimycin A?

1.319

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.371

PA_110-50 ug/mL Antitubercular compound PA-1?

0.256

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.060

PA8240.2-2 ug/mL PA-824?

1.146

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.130

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.213

Verapamil50 uM Verapamil?

-0.055

mercaptoethanol2 mM 2-Mercaptoethanol?

1.298

methoxatin10-20 ug/mL Methoxatin?